Ken Fisher's SNY Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 12.14 M shares of Sanofi (SNY) worth $588.33 M, representing 0.20% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in SNY, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2023, adding 1.99 M shares. Largest reduction occurred in Q3 2022, reducing 3.63 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -438,131 | Reduce 3.48% | 12.14 M | $48.46 |
| Q3 2025 | -556,620 | Reduce 4.24% | 12.58 M | $47.20 |
| Q2 2025 | -430,963 | Reduce 3.18% | 13.14 M | $48.31 |
| Q1 2025 | +1.06 M | Add 8.43% | 13.57 M | $55.46 |
| Q4 2024 | -848,083 | Reduce 6.35% | 12.51 M | $48.23 |
| Q3 2024 | -239,392 | Reduce 1.76% | 13.36 M | $57.63 |
| Q2 2024 | -349,081 | Reduce 2.50% | 13.6 M | $48.52 |
| Q1 2024 | -342,808 | Reduce 2.40% | 13.95 M | $48.60 |
| Q4 2023 | -652,327 | Reduce 4.37% | 14.29 M | $49.73 |
| Q3 2023 | +1.99 M | Add 15.33% | 14.94 M | $53.64 |
| Q2 2023 | -394,643 | Reduce 2.96% | 12.96 M | $53.90 |
| Q1 2023 | -430,041 | Reduce 3.12% | 13.35 M | $54.42 |
| Q4 2022 | -204,875 | Reduce 1.46% | 13.78 M | $48.43 |
| Q3 2022 | -3.63 M | Reduce 20.59% | 13.99 M | $38.02 |
| Q2 2022 | -320,069 | Reduce 1.78% | 17.61 M | $50.03 |
| Q1 2022 | -48,854 | Reduce 0.27% | 17.93 M | $51.34 |
| Q4 2021 | +75,166 | Add 0.42% | 17.98 M | $50.10 |
| Q3 2021 | +21,337 | Add 0.12% | 17.91 M | $48.21 |
| Q2 2021 | -247,533 | Reduce 1.37% | 17.89 M | $52.66 |
| Q1 2021 | -82,259 | Reduce 0.45% | 18.13 M | $49.46 |
| Q4 2020 | -409,356 | Reduce 2.20% | 18.21 M | $48.59 |
| Q3 2020 | +468,585 | Add 2.58% | 18.62 M | $50.17 |
| Q2 2020 | +493,628 | Add 2.79% | 18.16 M | $51.05 |
| Q1 2020 | +114,682 | Add 0.65% | 17.66 M | $43.72 |
| Q4 2019 | +170,342 | Add 0.98% | 17.55 M | $50.20 |
| Q3 2019 | +508,580 | Add 3.01% | 17.38 M | $46.33 |
| Q2 2019 | +367,961 | Add 2.23% | 16.87 M | $43.27 |
| Q1 2019 | +459,410 | Add 2.86% | 16.5 M | $44.28 |
| Q4 2018 | +414,369 | Add 2.65% | 16.04 M | $43.41 |
| Q3 2018 | +4,121 | Add 0.03% | 15.63 M | $44.67 |
| Q2 2018 | +549,110 | Add 3.64% | 15.62 M | $40.01 |
| Q1 2018 | +572,694 | Add 3.95% | 15.07 M | $40.08 |
| Q4 2017 | +418,501 | Add 2.97% | 14.5 M | $43.00 |
| Q3 2017 | +443,799 | Add 3.25% | 14.08 M | $49.79 |
| Q2 2017 | +1.02 M | Add 8.11% | 13.64 M | $47.91 |
| Q1 2017 | +123,470 | Add 0.99% | 12.62 M | $45.25 |
| Q4 2016 | +48,838 | Add 0.39% | 12.49 M | $40.44 |
| Q3 2016 | -1.19 M | Reduce 8.76% | 12.44 M | $38.19 |
| Q2 2016 | +91,233 | Add 0.67% | 13.64 M | $41.42 |
| Q1 2016 | +130,730 | Add 0.97% | 13.55 M | $43.77 |
| Q4 2015 | +120,254 | Add 0.90% | 13.42 M | $42.65 |
| Q3 2015 | +49,373 | Add 0.37% | 13.3 M | $47.47 |
| Q2 2015 | +188,498 | Add 1.44% | 13.25 M | $49.53 |
| Q1 2015 | -26,938 | Reduce 0.21% | 13.06 M | $49.44 |
| Q4 2014 | -60,614 | Reduce 0.46% | 13.09 M | $45.61 |
| Q3 2014 | +66,072 | Add 0.51% | 13.15 M | $56.43 |
| Q2 2014 | +153,173 | Add 1.18% | 13.08 M | $53.17 |
| Q1 2014 | +116,737 | Add 0.91% | 12.93 M | $52.28 |
| Q4 2013 | -18,344 | Reduce 0.14% | 12.81 M | $53.63 |
| Q3 2013 | +19,148 | Add 0.15% | 12.83 M | $50.63 |
| Q2 2013 | +12.81 M | Add 0.00% | 12.81 M | $51.51 |
Ken Fisher's Sanofi Investment FAQs
Ken Fisher first purchased Sanofi (SNY) in Q2 2013, acquiring 12,808,861 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Sanofi (SNY) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to Sanofi (SNY) was in Q2 2013, adding 12,808,861 shares worth $659.78 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 12,140,615 shares of Sanofi (SNY), valued at approximately $588.33 M.
As of the Q4 2025 filing, Sanofi (SNY) represents approximately 0.20% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Sanofi (SNY) was 18,624,240 shares, as reported at the end of Q3 2020.